EPL EPL Q1 FY27 results (Apr–Jun 2026) and concall
EPL Ltd delivered a strong Q1 FY27, achieving 25.3% revenue growth and 15.2% EBITDA increase, driven by robust performance in Beauty & Cosmetics and Oral Care across all geographies. The company successfully passed on cost increases and raised its revenue growth guidance to high teens, while maintaining margin targets. Despite a slight PAT decline due to tax rate effects and increased working capital, management expressed confidence in its strategy and the ongoing Indovida merger.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 25.3%, net profit up 0.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,086 | 1,014 | 1,105 | 1,108 | 1,206 +11% | 1,149 +13% | 1,300 +18% | 1,388 +25% |
| EBITDA | 219 | 202 | 228 | 227 | 252 +15% | 230 +14% | 256 +12% | 261 +15% |
| Net profit | 88 | 94 | 116 | 101 | 106 +20% | 83 −12% | 103 −11% | 101 +0% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
